Verastem, Inc.
General ticker "VSTM" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $344.9M (TTM average)
Verastem, Inc. follows the US Stock Market performance with the rate: 41.8%.
Estimated limits based on current volatility of 3.2%: low 9.86$, high 10.51$
Factors to consider:
- Total employees count: 73 (+28.1%) as of 2023
- Top business risk factors: Regulatory and compliance, Clinical trial delays, Product development risks, Funding requirements, Market competition
- Current price 87.5% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.80$, 5.65$]
- 2025-12-31 to 2026-12-31 estimated range: [1.29$, 4.16$]
Financial Metrics affecting the VSTM estimates:
- Positive: with PPE of -1.2 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -70.90 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 3.09 <= 3.41
- Negative: negative Net income
Short-term VSTM quotes
Long-term VSTM plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $2.60MM | $0.00MM | $10.00MM |
| Operating Expenses | $75.53MM | $92.08MM | $124.96MM |
| Operating Income | $-72.94MM | $-92.08MM | $-114.96MM |
| Non-Operating Income | $-0.88MM | $4.72MM | $-15.50MM |
| Interest Expense | $2.14MM | $4.14MM | $4.56MM |
| R&D Expense | $50.56MM | $61.36MM | $81.33MM |
| Income(Loss) | $-73.81MM | $-87.37MM | $-130.45MM |
| Taxes | $0.00MM | $0.00MM | $0.18MM |
| Profit(Loss)* | $-73.81MM | $-87.37MM | $-130.64MM |
| Stockholders Equity | $47.39MM | $57.37MM | $-28.89MM |
| Assets | $95.05MM | $149.72MM | $101.54MM |
| Operating Cash Flow | $-63.67MM | $-86.46MM | $-104.77MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.03MM |
| Investing Cash Flow | $66.19MM | $-44.45MM | $59.97MM |
| Financing Cash Flow | $51.78MM | $134.19MM | $54.78MM |
| Earnings Per Share** | $-4.57 | $-3.96 | $-3.66 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.